Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimmich

Showing results (291-300 of 331) with videos related to

Pageof 34
Sort By:
Geburtshilfe Und Frauenheilkunde|February 10, 2025
Vaginal-operative Birth: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/023, 11/2023)Peter Jakubowski, Harald Abele, Christian Bamberg, et al.
Clinical Lung Cancer|January 27, 2018
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL TrialSuresh S Ramalingam, Maurice Pérol, Martin Reck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2025
Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphyH S A Tingen, M Berends, A Tubben, et al.
Geburtshilfe Und Frauenheilkunde|February 10, 2025
Shoulder Dystocia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/098, 10/2024)Peter Jakubowski, Harald Abele, Christian Bamberg, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|June 10, 2025
Shoulder Dystocia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/098, 10/2024)Peter Jakubowski, Harald Abele, Christian Bamberg, et al.
The Journal of Biological Chemistry|October 8, 2003
Inhibition of fructose-1,6-bisphosphatase by a new class of allosteric effectorsJun-Young Choe, Scott W Nelson, Kristen L Arienti, et al.
Annals of Hematology|August 15, 2024
Diagnostic performance of liver stiffness as marker of liver involvement in systemic immunoglobulin light chain (AL) amyloidosisAnne F Brunger, Hendrea S A Tingen, Johan Bijzet, et al.
Clinical Lung Cancer|June 29, 2026
Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet StudyRajiv Shah, Eva L Buchmeier, Hans-Georg Kopp, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 18, 2019
A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC PatientsGiorgio Scagliotti, Denis Moro-Sibilot, Jens Kollmeier, et al.
Therapeutic Advances in Medical Oncology|June 9, 2021
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancerMartin Metzenmacher, Hans-Georg Kopp, Frank Griesinger, et al.
Pageof 34

Showing results (291-300 of 331) with videos related to

Sort By:
Pageof 34
Geburtshilfe Und Frauenheilkunde|February 10, 2025
Vaginal-operative Birth: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/023, 11/2023)Peter Jakubowski, Harald Abele, Christian Bamberg, et al.
Clinical Lung Cancer|January 27, 2018
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL TrialSuresh S Ramalingam, Maurice Pérol, Martin Reck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 22, 2025
Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphyH S A Tingen, M Berends, A Tubben, et al.
Geburtshilfe Und Frauenheilkunde|February 10, 2025
Shoulder Dystocia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/098, 10/2024)Peter Jakubowski, Harald Abele, Christian Bamberg, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|June 10, 2025
Shoulder Dystocia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/098, 10/2024)Peter Jakubowski, Harald Abele, Christian Bamberg, et al.
The Journal of Biological Chemistry|October 8, 2003
Inhibition of fructose-1,6-bisphosphatase by a new class of allosteric effectorsJun-Young Choe, Scott W Nelson, Kristen L Arienti, et al.
Annals of Hematology|August 15, 2024
Diagnostic performance of liver stiffness as marker of liver involvement in systemic immunoglobulin light chain (AL) amyloidosisAnne F Brunger, Hendrea S A Tingen, Johan Bijzet, et al.
Clinical Lung Cancer|June 29, 2026
Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet StudyRajiv Shah, Eva L Buchmeier, Hans-Georg Kopp, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 18, 2019
A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC PatientsGiorgio Scagliotti, Denis Moro-Sibilot, Jens Kollmeier, et al.
Therapeutic Advances in Medical Oncology|June 9, 2021
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancerMartin Metzenmacher, Hans-Georg Kopp, Frank Griesinger, et al.
Pageof 34